Asia Pacific Atrial Fibrillation Surgery Market is a worth of USD 363.9 million by 2022 – Market data forecast
Asia Pacific Atrial Fibrillation Surgery Market By Surgical Procedure By Product And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017 –2022)
(EMAILWIRE.COM, February 02, 2018 ) The Asia Pacific Atrial Fibrillation Surgery Market was worth USD 164.9 million in 2017, and is expected to grow at a CAGR of 17.2%, to reach USD 363.9 million by 2022. Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, shortness of breath and heart palpitations.
View full report @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/
Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.
Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.
Get free sample report @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/request-sample
The Atrial Fibrillation Surgery Market is categorized based on the surgical procedure, product and region. Based on surgical procedure, the market is categorized into Catheter Ablation procedure and Surgical Ablation or Maze procedure. Based on product, the market is categorized into Catheter Ablation and Surgical Ablation. Catheter ablation surgical devices are expected to be the largest segment and are also expected be the fastest growing segment due to its high acceptance in surgical procedures.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/inquire
Based on geography, the market is categorized into China, India, Japan, Australia and South Korea. Asia Pacific is expected to be the fastest growing segment due to the large number of geriatric population who has a high risk of heart diseases in countries such as India and China.
Some of the major players in this region are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.
Market Segmentation
1)Surgical Procedure
2) Product
Buy now @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View full report @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/
Atrial fibrillation, if left untreated doubles the risk of heart related deaths and stokes in humans. Treatment for atrial fibrillation includes rhythm control, heart rate control, preventing heart failure and blood clots. But treatment and medication doesn’t work in all cases. In that case, surgical procedure is conducted to destroy the heart tissue in the area that is causing erratic electrical signals and restore the heart to a normal rhythm either by using catheters or during an open heart surgery.
Growing number of atrial fibrillation cases all over the globe is the major factor driving this market. Lower treatment costs and reimbursement policies are expected to drive the market. Favourable regulations and increasing preference for surgeries are also driving the market. However, lack of awareness about surgeries or health risks posed by atrial fibrillation among the people suffering from the issue and availability of several pharmaceutical alternatives are restraining the market.
Get free sample report @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/request-sample
The Atrial Fibrillation Surgery Market is categorized based on the surgical procedure, product and region. Based on surgical procedure, the market is categorized into Catheter Ablation procedure and Surgical Ablation or Maze procedure. Based on product, the market is categorized into Catheter Ablation and Surgical Ablation. Catheter ablation surgical devices are expected to be the largest segment and are also expected be the fastest growing segment due to its high acceptance in surgical procedures.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/inquire
Based on geography, the market is categorized into China, India, Japan, Australia and South Korea. Asia Pacific is expected to be the fastest growing segment due to the large number of geriatric population who has a high risk of heart diseases in countries such as India and China.
Some of the major players in this region are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.
Market Segmentation
1)Surgical Procedure
2) Product
Buy now @ https://www.marketdataforecast.com/market-reports/asia-pacific-atrial-fibrillation-surgery-market-4070/
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Contact Information:
Market Data Forecast
Abhishek shukla
Tel: 9985550206
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast
Abhishek shukla
Tel: 9985550206
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results